We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Globalization Bill Includes Generic Plant Inspections
House Globalization Bill Includes Generic Plant Inspections
February 3, 2009
New legislation would require FDA inspections of generic and brand drug facilities and device plants in the U.S. and abroad every two years, unless the agency decides a facility’s record requires fewer reviews.